The coronavirus vaccines made by Pfizer and Moderna rely heavily on two fundamental discoveries that emerged from federally funded research.
The gene expression and chromatin accessibility atlases will accelerate the study of the genomics of normal and abnormal development.
The vaccine has to be stored at -70 degrees Celsius. Typical freezers don’t get that cold, making distribution of this vaccine a logistical nightmare.
Many have pinned their hopes on a COVID-19 vaccine being developed at “warp speed.” But some scientific experts warn they’re all expecting too much, too soon.
The way we train our immune systems now to respond to SARS-CoV-2 could impact how well our bodies can respond to future coronaviruses.
If you look at all the steps needed for a coronavirus vaccine to be scientifically validated and cleared for public use. tt’s a long shot in 38 days.
A great deal of uncertainty remains about what happened to the unnamed patient, to the frustration of those avidly following the progress of vaccine testing.
With all the news swirling around convalescent plasma, we thought we’d break it down for you.
The agency must give outside scientists and the public the opportunity to see the data and the FDA’s reasoning before coming to such a decision, critics say.
Mapping the COVID-19 ‘family tree’
It is likely we’ll eventually have a coronavirus vaccine — but perhaps not as quickly as some expect. From development, to clinical trials and distribution, there are tremendous challenges lying ahead.
Findings may help explain why these energy-producing cellular organelles begin to fail as we age.
Medical supply companies with boards that included at least two women recalled life-threatening products almost a month sooner than those with all-male boards,
From the research lab to your doctor’s office – here’s what happens in phase 1, 2, 3 drug trials
Convalescent plasma treatment involves using plasma from people who have recovered from COVID-19 and infusing it into patients who currently have the disease.